|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



*
Intramural Research Support Program, Science Application International Corp.-Frederick, and
Basic Research Laboratory, Division of Basic Sciences, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702;
Department of Medicine and Biochemistry/Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202; and
Department of Integrative Biology and Pharmacology, University of Texas, Houston, TX 77030
The ubiquitin-dependent proteasome-mediated (Ub-Pr) degradation
pathway has been shown to regulate a large variety of substrates,
including nuclear, cytosolic, and membrane proteins. In mammalian
systems, polyubiquitin modification has been identified in a number of
cell surface receptors for more than a decade; however, its biological
significance has remained unclear until recently. For growth factor
receptors with intrinsic tyrosine kinase domains, polyubiquitination is
believed to trigger the internalization and subsequent degradation via
the lysosomal pathway. In this study we provide the first evidence that
non-tyrosine kinase-type cytokine surface receptors, IL-9R
-chain,
IL-2 receptor
-chain, and erythropoietin receptor, can be
polyubiquitinated and degraded by proteasomes. The Ub-Pr pathway
regulates both the basal level turnover and the ligand-induced
degradation of the receptors. A previously identified putative
molecular chaperon, valosin-containing protein, undergoes tyrosine
phosphorylation in a cytokine-dependent manner and associates with the
receptor complexes following receptor engagement, suggesting that
valosin-containing protein may target the ubiquitinated receptors to
the proteasome for degradation.
This article has been cited by other articles:
![]() |
J. Aker and S. C. de Vries Plasma Membrane Receptor Complexes Plant Physiology, August 1, 2008; 147(4): 1560 - 1564. [Full Text] [PDF] |
||||
![]() |
L. Meyer, B. Deau, H. Forejtnikova, D. Dumenil, F. Margottin-Goguet, C. Lacombe, P. Mayeux, and F. Verdier {beta}-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation Blood, June 15, 2007; 109(12): 5215 - 5222. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Jiang, J. Huang, W. Q. Li, T. Cavinato, J. R. Keller, and S. K. Durum Role of the Intracellular Domain of IL-7 Receptor in T Cell Development J. Immunol., January 1, 2007; 178(1): 228 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Vij, S. Fang, and P. L. Zeitlin Selective Inhibition of Endoplasmic Reticulum-associated Degradation Rescues {Delta}F508-Cystic Fibrosis Transmembrane Regulator and Suppresses Interleukin-8 Levels: THERAPEUTIC IMPLICATIONS J. Biol. Chem., June 23, 2006; 281(25): 17369 - 17378. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Staub and D. Rotin Role of Ubiquitylation in Cellular Membrane Transport Physiol Rev, April 1, 2006; 86(2): 669 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Walrafen, F. Verdier, Z. Kadri, S. Chretien, C. Lacombe, and P. Mayeux Both proteasomes and lysosomes degrade the activated erythropoietin receptor Blood, January 15, 2005; 105(2): 600 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Wang, C. Song, X. Yang, and C.-C. H. Li D1 Ring Is Stable and Nucleotide-independent, whereas D2 Ring Undergoes Major Conformational Changes during the ATPase Cycle of p97-VCP J. Biol. Chem., August 29, 2003; 278(35): 32784 - 32793. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Friedman, D. Nimbalkar, and F. W. Quelle Erythropoietin Receptors Associate with a Ubiquitin Ligase, p33RUL, and Require Its Activity for Erythropoietin-induced Proliferation J. Biol. Chem., July 11, 2003; 278(29): 26851 - 26861. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Song, Q. Wang, and C.-C. H. Li ATPase Activity of p97-Valosin-containing Protein (VCP). D2 MEDIATES THE MAJOR ENZYME ACTIVITY, AND D1 CONTRIBUTES TO THE HEAT-INDUCED ACTIVITY J. Biol. Chem., January 31, 2003; 278(6): 3648 - 3655. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nagahama, M. Suzuki, Y. Hamada, K. Hatsuzawa, K. Tani, A. Yamamoto, and M. Tagaya SVIP Is a Novel VCP/p97-interacting Protein Whose Expression Causes Cell Vacuolation Mol. Biol. Cell, January 1, 2003; 14(1): 262 - 273. [Abstract] [Full Text] |
||||
![]() |
D. Ungureanu, P. Saharinen, I. Junttila, D. J. Hilton, and O. Silvennoinen Regulation of Jak2 through the Ubiquitin-Proteasome Pathway Involves Phosphorylation of Jak2 on Y1007 and Interaction with SOCS-1 Mol. Cell. Biol., May 15, 2002; 22(10): 3316 - 3326. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Rabinovich, A. Kerem, K.-U. Frohlich, N. Diamant, and S. Bar-Nun AAA-ATPase p97/Cdc48p, a Cytosolic Chaperone Required for Endoplasmic Reticulum-Associated Protein Degradation Mol. Cell. Biol., January 15, 2002; 22(2): 626 - 634. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |